IMCD further strengthens its pharmaceutical offering in the Americas with the acquisition of Sachs Chemical, Inc. - Yahoo Finance
| IMCD Stock | EUR 140.55 0.55 0.39% |
Slightly above 54% of IMCD NV's investor base is interested to short. The analysis of current outlook of investing in IMCD NV suggests that many traders are impartial regarding IMCD NV's prospects. IMCD NV's investing sentiment can be driven by a variety of factors including economic data, IMCD NV's earnings reports, geopolitical events, and overall market trends.
IMCD NV stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of IMCD daily returns and investor perception about the current price of IMCD NV as well as its diversification or hedging effects on your existing portfolios.
IMCD |
IMCD further strengthens its pharmaceutical offering in the Americas with the acquisition of Sachs Chemical, Inc. Yahoo Finance
Read at news.google.com
 |
IMCD NV Fundamental Analysis
We analyze IMCD NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IMCD NV using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of IMCD NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
IMCD NV is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
IMCD NV Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with IMCD NV stock to make a market-neutral strategy. Peer analysis of IMCD NV could also be used in its relative valuation, which is a method of valuing IMCD NV by comparing valuation metrics with similar companies.
Peers
IMCD NV Related Equities
| ASRNL | ASR Nederland | 0.29 | ||||
| ASM | ASM International | 0.25 | ||||
| AALB | Aalberts Industries | 0.47 | ||||
| WKL | Wolters Kluwer | 0.99 |
Additional Tools for IMCD Stock Analysis
When running IMCD NV's price analysis, check to measure IMCD NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IMCD NV is operating at the current time. Most of IMCD NV's value examination focuses on studying past and present price action to predict the probability of IMCD NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IMCD NV's price. Additionally, you may evaluate how the addition of IMCD NV to your portfolios can decrease your overall portfolio volatility.